Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
367M
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
26.4M
-
Shares change
-
+1.06M
-
Total reported value, excl. options
-
$766M
-
Value change
-
+$33.8M
-
Put/Call ratio
-
3.22
-
Number of buys
-
38
-
Number of sells
-
-24
-
Price
-
$29.02
Significant Holders of Legend Biotech Corp - COMMON STOCK (LEGN) as of Q1 2021
84 filings reported holding LEGN - Legend Biotech Corp - COMMON STOCK as of Q1 2021.
Legend Biotech Corp - COMMON STOCK (LEGN) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.4M shares
of 367M outstanding shares and own 7.19% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (2.76M shares), Hudson Bay Capital Management LP (2.17M shares), ALLIANCEBERNSTEIN L.P. (2.12M shares), FEDERATED HERMES, INC. (2.11M shares), CAPITAL INTERNATIONAL INC (1.92M shares), Point72 Asset Management, L.P. (1.64M shares), Johnson & Johnson Innovation - JJDC, Inc. (1.63M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.3M shares), Capital World Investors (1.19M shares), and MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC (1.05M shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.